Huacheng Import and Export Data Observation reported that the Information Office of the Hebei Provincial Government held a press conference on the 22nd to announce that the Shijiazhuang Air Port was added as a drug import port. Coordinated development. On the same day, China Hebei Port Drug Inspection Institute was officially established and put into operation.
On August 26, the State Drug Administration of China and the General Administration of Customs of China jointly issued the "Announcement on Adding Shijiazhuang Air Port as a Drug Import Port". With the approval of the State Council of China, it was agreed to add Shijiazhuang Air Port as a drug import port. According to Huacheng Import and Export Data Observation Report, Shijiazhuang has become the 28th city with a drug import port among more than 300 cities above the prefecture level in the country.
According to Huacheng Import and Export Data Observation Report, the successful approval of the Shijiazhuang drug import port is conducive to promoting the coordinated development of Beijing-Tianjin-Hebei. In recent years, Hebei has solidly promoted the coordinated development of Beijing-Tianjin-Hebei and the construction of the Xiongan New Area, undertaken non-capital functions in Beijing and industrial transfer. Nearly 150 pharmaceutical manufacturers have relocated from Beijing and Tianjin to Hebei, and the demand for pharmaceutical import and export business in Hebei has grown rapidly.
Therefore, its successful approval can further enhance the level of Beijing-Tianjin-Hebei market integration, support the transfer of non-capital functions from Beijing to Hebei, drive Beijing-Tianjin-Hebei cities to take advantage of the pharmaceutical industry, reduce the burden of Beijing-Tianjin drug import customs clearance and inspection, and radiate the surrounding areas. provinces, resulting in greater synergies.
At the same time, it is conducive to promoting the development of the pharmaceutical industry in Hebei Province. Hebei is a major province in the production and distribution of pharmaceuticals, and the operating income of the pharmaceutical industry above designated size exceeds RMB 100 billion. At present, Hebei has 412 pharmaceutical production enterprises, 594 pharmaceutical wholesale enterprises, and more than 33,000 pharmaceutical retail enterprises, forming pharmaceutical industry clusters such as Shijiazhuang, Cangzhou, Anguo, and Beidaihe.
Huacheng Import and Export Data Observation reports that the approval of the Shijiazhuang drug import port can significantly optimize the pharmaceutical business environment in Hebei, enhance the policy attractiveness to pharmaceutical companies, help pharmaceutical companies to participate in the international pharmaceutical circulation, and facilitate the development of import and export business. , to promote the pharmaceutical industry to achieve a new leap-forward development.
Watson & Band’s import and export data observation report can make Hebei’s imported drugs no longer “bypass” the ports of other provinces and cities, which can effectively reduce the intermediate links of imported drugs, shorten the drug import cycle, reduce the cost of imported drugs, and alleviate the expensive and slow purchase of imported drugs. , Difficulty and other outstanding problems.